Your browser doesn't support javascript.
loading
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
Pelaia, Corrado; Calabrese, Cecilia; Barbuto, Sarah; Busceti, Maria Teresa; Preianò, Mariaimmacolata; Gallelli, Luca; Savino, Rocco; Vatrella, Alessandro; Pelaia, Girolamo.
Afiliación
  • Pelaia C; Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Italy.
  • Calabrese C; Department of Cardio-Thoracic and Respiratory Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Barbuto S; Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Italy.
  • Busceti MT; Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Italy.
  • Preianò M; Department of Health Sciences, University "Magna Græcia" of Catanzaro, Italy.
  • Gallelli L; Department of Health Sciences, University "Magna Græcia" of Catanzaro, Italy.
  • Savino R; Department of Health Sciences, University "Magna Græcia" of Catanzaro, Italy.
  • Vatrella A; Department of Medicine, Surgery and Dentistry, Section of Respiratory Diseases, University of Salerno, Italy.
  • Pelaia G; Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Italy. Electronic address: pelaia@unicz.it.
Pulm Pharmacol Ther ; 54: 25-30, 2019 02.
Article en En | MEDLINE | ID: mdl-30414440

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Eosinófilos / Omalizumab Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Eosinófilos / Omalizumab Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Italia